Howard B Rosen's Net Worth

$21.5 Thousand

Estimate Recalculated Dec 3, 2025 07:31PM EST

Who is Howard B Rosen

Howard B Rosen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COTHERIX INC, KALA BIO, Inc., ACELRX PHARMACEUTICALS INC, and PHARSIGHT CORP.

SEC CIK

Howard B Rosen's CIK is 0001307068

Past Insider Trading and Trends

2023 was Howard B Rosen's most active year for acquiring shares with 7 total transactions. Howard B Rosen's most active month to acquire stocks was the month of May. 2008 was Howard B Rosen's most active year for disposing of shares, totalling 5 transactions. Howard B Rosen's most active month to dispose stocks was the month of April. 2016 saw Howard B Rosen paying a total of $33,271.56 for 810,206 shares, this is the most they've acquired in one year. In 2008 Howard B Rosen cashed out on 46,832 shares for a total of $107,200.15, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COTHERIX INC

Investor
Updated May 26, 2006
Form 4
6.06K
May 26, 2006
6.06K
Grant
May 25
Form 4
18.18K
Sep 20, 2005
18.18K
Grant
Sep 16
Form 3
Sep 20, 2005
Showing 3 results

KALA BIO, Inc.

Investor
Updated Jun 12, 2024
Form 4
36.44%
4.55K
Jun 12, 2024
17.20K
Grant
Jun 11
Form 4
654.28%
22.24K
Jun 23, 2023
25.80K
Grant
Jun 22
Form 4
Jun 02, 2023
3.56K
Acq/Dis
May 31
Form 4
40.00K
Jun 17, 2022
40.00K
Grant
Jun 16
Form 4
80.57%
20.00K
Jun 21, 2021
53.06K
Grant
Jun 17
Form 4
414.59%
20.00K
Jun 29, 2020
33.06K
Grant
Jun 25
Form 4
$0.60
$2.87K
Jun 29, 2020
13.06K
Options
Aug 19
Form 4
21.00K
Jun 07, 2019
21.00K
Grant
Jun 05
Form 4
154.32%
5.00K
$5.42
$27.10K
Jun 03, 2019
8.24K
Purchase
May 30
Form 4
12.96K
Jun 14, 2018
12.96K
Grant
Jun 12
Form 4
12.96K
Jul 21, 2017
12.96K
Grant
Jul 19
Form 3
Jul 19, 2017
3.24K
Showing 12 results

ACELRX PHARMACEUTICALS INC

CEO
Updated Dec 13, 2023
Form 4
86.33%
4.07K
Dec 13, 2023
8.78K
Grant
Oct 10
Form 4
59.05%
46.50K
Jul 15, 2022
125.25K
Grant
Jul 15
Form 4
43.64%
30.00K
Jun 17, 2021
98.75K
Grant
Jun 17
Form 4
36.73%
22.50K
Jun 16, 2020
83.75K
Grant
Jun 16
Form 4
19.57%
11.25K
Jun 25, 2019
68.75K
Grant
Jun 25
Form 4
15.00K
Jun 14, 2018
15.00K
Grant
Jun 14
Form 4
15.00K
Jun 15, 2017
15.00K
Grant
Jun 15
Form 4
366.00K
Feb 17, 2017
366.00K
Grant
Feb 07
Form 4
25.65%
10.21K
$3.26
$33.27K
May 16, 2016
50.00K
Purchase
May 13
Form 4
800.00K
Mar 30, 2016
800.00K
Grant
Mar 28
Form 4
805.64%
35.40K
May 20, 2015
39.79K
Purchase
May 19
Form 4
240.00K
Apr 03, 2015
240.00K
Grant
Apr 01
Form 4
15.00K
Jul 28, 2014
15.00K
Grant
Jul 24
Form 4
15.00K
Sep 16, 2013
15.00K
Grant
Sep 12
Form 4
12.50K
Jul 26, 2012
12.50K
Grant
Jul 24
Form 4
4.39K
Mar 04, 2011
4.39K
Grant
Mar 02
Form 3
Feb 10, 2011
Showing 17 results

PHARSIGHT CORP

Investor
Updated Oct 31, 2008
Form 4
-100.00%
-46.83K
$1.85
-$107.20K
Oct 31, 2008
Disposition
Oct 31
Form 4
3.50K
Aug 28, 2008
3.50K
Grant
Aug 28
Form 4
10.00K
Aug 09, 2007
10.00K
Grant
Aug 09
Form 4
10.00K
Aug 11, 2006
10.00K
Grant
Aug 11
Form 4
10.00K
Aug 12, 2005
10.00K
Grant
Aug 11
Form 4
100.00K
Oct 26, 2004
100.00K
Grant
Oct 21
Form 3
Oct 26, 2004
Showing 7 results